` Comparison: SCL vs GIVN - Alpha Spread

SCL
vs
GIVN

Over the past 12 months, SCL has outperformed GIVN, delivering a return of -16% compared to the GIVN's 25% drop.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
SCL
GIVN
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

SCL Intrinsic Value
HIDDEN
Show
GIVN Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Stepan Co
NYSE:SCL
51.74 USD
Givaudan SA
SIX:GIVN
3 061 CHF
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
SCL, GIVN

SCL
GIVN
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Stepan Co
Revenue
Givaudan SA
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
SCL, GIVN

SCL
GIVN
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Stepan Co
NYSE:SCL
Givaudan SA
SIX:GIVN
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

SCL
11.6%
GIVN
43.5%
LTM 3Y Avg 5Y Avg 10Y Avg
Stepan Co
Givaudan SA

Operating Margin

SCL
3%
GIVN
18.3%
LTM 3Y Avg 5Y Avg 10Y Avg
Stepan Co
Givaudan SA

Net Margin

SCL
2%
GIVN
14.3%
LTM 3Y Avg 5Y Avg 10Y Avg
Stepan Co
Givaudan SA

FCF Margin

SCL
1.4%
GIVN
16.2%
LTM 3Y Avg 5Y Avg 10Y Avg
Stepan Co
Givaudan SA

ROE

SCL
3.9%
GIVN
23.5%
LTM 3Y Avg 5Y Avg 10Y Avg
Stepan Co
Givaudan SA

ROA

SCL
2%
GIVN
8.9%
LTM 3Y Avg 5Y Avg 10Y Avg
Stepan Co
Givaudan SA

ROIC

SCL
2.7%
GIVN
11.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Stepan Co
Givaudan SA

ROCE

SCL
4.1%
GIVN
14.5%
LTM 3Y Avg 5Y Avg 10Y Avg
Stepan Co
Givaudan SA

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
SCL, GIVN

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
SCL, GIVN

Performance Gap Between SCL and GIVN
HIDDEN
Show

Performance By Year
SCL, GIVN

Loading
SCL
GIVN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare SCL to other stocks
SHW
Sherwin-Williams Co
More expensive
vs SCL
ECL
Ecolab Inc
More expensive
vs SCL
4063
Shin-Etsu Chemical Co Lt...
More expensive
vs SCL
600309
Wanhua Chemical Group Co...
More expensive
vs SCL
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett